$24.64
-1.39 (-5.34%)
Performance
1D
-2.34%
1W
-23.24%
1M
-10.40%
3M
+5.30%
6M
+54.58%
1Y
-3.79%
YTD
-8.67%
Open$26.27
Previous Close$26.03
Day High$26.58
Day Low$24.09
52W High$36.50
52W Low$14.19
Volume—
Avg Volume3.73M
Market Cap7.36B
P/E Ratio69.97
EPS$0.37
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$29.48
Below
SMA 200
$21.67
Above
RSI (14)
36.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+25.5% upside
Current
$24.64
$24.64
Target
$30.92
$30.92
$20.23
$30.92 avg
$48.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.45B | 1.64B | 1.52B |
| Net Income | -121,564,288 | 316.28M | 306.08M |
| Profit Margin | -8.4% | 19.3% | 20.1% |
| EBITDA | 45.17M | 415.16M | 429.14M |
| Free Cash Flow | — | 185.08M | 215.40M |
| Rev Growth | — | +14.2% | +10.8% |
| Debt/Equity | 0.66 | 0.26 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |